Page last updated: 2024-08-23

nicorandil and Cardiomyopathy, Congestive

nicorandil has been researched along with Cardiomyopathy, Congestive in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC	1
Brixius, K; Hoischen, S; Müller-Ehmsen, J; Schwinger, RH	1

Other Studies

2 other study(ies) available for nicorandil and Cardiomyopathy, Congestive

Article	Year
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation, 2013, Apr-23, Volume: 127, Issue:16 Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentiation; Cell Line; Cell Size; Cisapride; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Embryoid Bodies; Embryonic Stem Cells; Gene Expression Profiling; Genetic Predisposition to Disease; HEK293 Cells; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ion Channels; Kidney; Long QT Syndrome; Myocytes, Cardiac; Myofibrils; Nicorandil; Patch-Clamp Techniques; Quinazolines; Verapamil	2013
Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3 Topics: Adenosine Triphosphate; Adult; Calcium; Cardiomyopathy, Dilated; Coronary Vessels; Female; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Potassium Channels; Vascular Resistance; Vasodilator Agents	1996

Article

Year

Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Circulation, 2013, Apr-23, Volume: 127, Issue:16

Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentiation; Cell Line; Cell Size; Cisapride; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Embryoid Bodies; Embryonic Stem Cells; Gene Expression Profiling; Genetic Predisposition to Disease; HEK293 Cells; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ion Channels; Kidney; Long QT Syndrome; Myocytes, Cardiac; Myofibrils; Nicorandil; Patch-Clamp Techniques; Quinazolines; Verapamil

2013

Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.

The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3

Topics: Adenosine Triphosphate; Adult; Calcium; Cardiomyopathy, Dilated; Coronary Vessels; Female; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Potassium Channels; Vascular Resistance; Vasodilator Agents

1996